APPLICATION
ANDA064070
TYPE
ANDA
ORIGINAL APPROVAL
1995-04-28
LATEST ACTION
1998-12-09
ROUTE
ORAL
DOSAGE FORM
FOR SUSPENSION
MARKETING STATUS
Discontinued
Products
CEFACLORDiscontinued
CEFACLOR EQ 375MG BASE/5ML · FOR SUSPENSION · ORAL
Approval history
1998-12-09Manufacturing (CMC) · Supplement 2AP
1997-05-30Manufacturing (CMC) · Supplement 1AP
1995-04-28OriginalAP
Source: FDA Drugs@FDA. SPEQ is not affiliated with the FDA; this is a reference view of public FDA data, not medical, legal, or regulatory advice.
Weekly Briefing
Read a past issue →Get the Weekly GxP Briefing
Curated regulatory intelligence — enforcement, recalls, guidance, and quality signals — in one practitioner-grade email each week. Free.